Tissue Regenix Group (FRA:LSW) FCF Margin %: -5.76% (As of Jun. 2025)


FRA:LSW Tissue Regenix Group PLC FRA:LSW
10 GF Score
Price €0.07
GF Value €0.84
! 5 Warning Signs
View Full Analysis

What is Tissue Regenix Group FCF Margin %?

Tissue Regenix Group FRA:LSW 10 FCF Margin % is -5.76% as of Jun. 2025. GuruFocus rates FRA:LSW with a GF Score™ of 10/100 and a GF Value™ of €0.84. The stock has 5 warning signs investors should review.

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Tissue Regenix Group's Free Cash Flow for the six months ended in Jun. 2025 was €-0.69 Mil. Tissue Regenix Group's Revenue for the six months ended in Jun. 2025 was €11.96 Mil. Therefore, Tissue Regenix Group's FCF Margin % for the quarter that ended in Jun. 2025 was -5.76%.

As of today, Tissue Regenix Group's current FCF Yield % is -85.70%.

The historical rank and industry rank for Tissue Regenix Group's FCF Margin % or its related term are showing as below:

FRA:LSW' s FCF Margin % Range Over the Past 10 Years
Min: -8381.54   Med: -52.18   Max: 0.68
Current: -16.9

During the past 13 years, the highest FCF Margin % of Tissue Regenix Group was 0.68%. The lowest was -8381.54%. And the median was -52.18%.

FRA:LSW's FCF Margin % is not ranked
in the Biotechnology industry.
Industry Median: -84.65 vs FRA:LSW: -16.90

Tissue Regenix Group FCF Margin % Related Terms

Tissue Regenix Group FCF Margin % Historical Data

* Premium members only.

The historical data trend for Tissue Regenix Group's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Tissue Regenix Group FCF Margin % Chart

Tissue Regenix Group Annual Data
Trend Jan15 Jan16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
FCF Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -48.08 -25.44 -9.74 0.68 -19.91

Tissue Regenix Group Semi-Annual Data
Jul15 Jan16 Jul16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25
FCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -8.09 10.79 -13.29 -26.89 -5.76

FRA:LSW vs VRTX, REGN, ALNY: FCF Margin % Comparison

For the Biotechnology subindustry, Tissue Regenix Group's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Tissue Regenix Group FCF Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Tissue Regenix Group's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Tissue Regenix Group's FCF Margin % falls into.


FRA:LSW
10GF Score
Tissue Regenix Group PLC FRA:LSW
FCF Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Tissue Regenix Group FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Tissue Regenix Group's FCF Margin for the fiscal year that ended in Dec. 2024 is calculated as

FCF Margin=Free Cash Flow (A: Dec. 2024 )/Revenue (A: Dec. 2024 )
=-5.447/27.357
=-19.91 %

Tissue Regenix Group's FCF Margin for the quarter that ended in Jun. 2025 is calculated as

FCF Margin=Free Cash Flow (Q: Jun. 2025 )/Revenue (Q: Jun. 2025 )
=-0.689/11.961
=-5.76 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about FCF Margin % →
What does a FCF Margin % of -5.76% mean?
Tissue Regenix Group (FRA:LSW) has a FCF Margin % of -5.76% as of Jun. 2025. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Tissue Regenix Group and its competitors.
Is Tissue Regenix Group's FCF Margin % too high?
Tissue Regenix Group's current FCF Margin % is -5.76%. Overall, Tissue Regenix Group has a GF Score™ of 10/100, reflecting its overall financial health beyond just this single metric.
How does Tissue Regenix Group's FCF Margin % compare to VRTX and REGN?
Tissue Regenix Group's FCF Margin % of -5.76% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Biotechnology company?
A good FCF Margin % depends on the Biotechnology industry context. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Tissue Regenix Group and its competitors. Tissue Regenix Group's current FCF Margin % is -5.76%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Tissue Regenix Group stock overvalued right now?
Tissue Regenix Group (FRA:LSW) has a current FCF Margin % of -5.76%. The stock's GF Value™ is €0.84, compared to a current price of €0.07 — trading 91.7% below its estimated fair value. The current FCF Margin % is -5.76%. Tissue Regenix Group's overall GF Score™ is 10/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Tissue Regenix Group (FRA:LSW), the current FCF Margin % is -5.76% as of Jun. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Tissue Regenix Group (FRA:LSW) Overvalued in 2026?

Based on GuruFocus' analysis, Tissue Regenix Group stock appears to be undervalued. The current stock price of €0.07 is trading 91.7% below its estimated GF Value™ of €0.84.

Key valuation signals for FRA:LSW:

  • FCF Margin %: -5.76%
  • GF Value™: €0.84 vs. price of €0.07 (91.7% below fair value)
  • GF Score™: 10/100 with 5 warning signs

No single metric tells the full story. See the FRA:LSW stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Tissue Regenix Group Business Description

Address Lotherton Way, Unit 3, Phoenix Court, Garforth, GBR, LS25 2GY
Tissue Regenix Group PLC is a pioneering medical technology company engaged in the development of regenerative products. The company incorporates dCELL and BioRinse technology, which helps to address complex and varying clinical needs. Its product portfolio includes Biosurgery, Orthopaedics, and Dental. The company has operations around the world, with special emphasis in the United States.
10GF Score

Get the complete analysis for FRA:LSW

FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.07
Price
€0.84
GF Value